
Quotient Limited QTNT
Quarterly report 2022-Q4
added 02-09-2023
Quotient Limited Shares 2011-2026 | QTNT
Annual Shares Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 91.6 M | 71.6 M | 54.9 M | 40.8 M | 28.1 M | 19.6 M | 14.8 M | 18.4 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.6 M | 14.8 M | 42.5 M |
Quarterly Shares Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.25 M | 3.71 M | 3.44 M | 2.57 M | 2.55 M | 2.54 M | 2.54 M | 101 M | 101 M | 83.9 M | 83.9 M | 80.5 M | 73.8 M | 73.8 M | 66.3 M | 66.1 M | 56.6 M | 56.6 M | 52.1 M | 45.6 M | 43.4 M | 37.7 M | 36.8 M | 29.6 M | 29.5 M | 27.7 M | 26.8 M | 25.4 M | 20.4 M | 18.3 M | 17.2 M | 17 M | 15.1 M | 14.4 M | 12.8 M | 342 K | 829 K | 144 K | 237 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | 144 K | 34.3 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 17.01 | -0.12 % | $ 179 M | ||
|
Agilent Technologies
A
|
304 M | $ 118.05 | 0.44 % | $ 35.9 B | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
53.3 M | $ 20.96 | 1.26 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
1.33 M | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Castle Biosciences
CSTL
|
27.8 M | $ 24.81 | 0.85 % | $ 689 M | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
49.6 M | $ 183.48 | -1.03 % | $ 9.09 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
28.8 M | $ 427.17 | -0.73 % | $ 12.3 B | ||
|
Myriad Genetics
MYGN
|
92.6 M | $ 4.01 | -20.18 % | $ 371 M | ||
|
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | ||
|
NeoGenomics
NEO
|
128 M | $ 8.89 | 0.28 % | $ 1.14 B | ||
|
National Research Corporation
NRC
|
22.4 M | $ 17.96 | -4.16 % | $ 402 M | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 15.03 | 0.87 % | $ 454 M | ||
|
Natera
NTRA
|
98.4 M | $ 217.47 | 5.17 % | $ 21.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
904 M | $ 27.16 | 2.68 % | $ 20 B | ||
|
Guardant Health
GH
|
125 M | $ 92.19 | 2.98 % | $ 11.6 B | ||
|
Personalis
PSNL
|
59.3 M | $ 6.01 | 8.09 % | $ 356 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
82.5 M | $ 123.63 | 1.9 % | $ 10.2 B | ||
|
Illumina
ILMN
|
159 M | $ 141.82 | 1.97 % | $ 22.5 B | ||
|
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
Senseonics Holdings
SENS
|
41.7 M | $ 5.38 | 7.6 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
4.42 M | $ 2.05 | 2.09 % | $ 9.07 M | ||
|
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
377 M | $ 472.27 | 1.18 % | $ 178 B | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.22 | 1.6 % | $ 5.1 M | ||
|
Lantheus Holdings
LNTH
|
67.5 M | $ 85.47 | -0.41 % | $ 5.77 B | ||
|
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.61 | 2.11 % | $ 61.9 M | ||
|
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 257.56 | 0.16 % | $ 21.4 B | ||
|
Twist Bioscience Corporation
TWST
|
59.8 M | $ 59.55 | 5.03 % | $ 3.56 B | ||
|
Celcuity
CELC
|
46.8 M | $ 139.94 | -1.24 % | $ 6.54 B | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
217 M | $ 9.16 | -1.13 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 189.52 | -0.69 % | $ 21 B | ||
|
Waters Corporation
WAT
|
59.5 M | $ 348.15 | 1.58 % | $ 20.7 B |